A multicentre, open-label, randomised phase III study comparing a new levonorgestrel intrauterine contraceptive system (LNG-IUS 8) with combined oral contraception in young women of reproductive age.

MLA

Borgatta, Lynn, et al. “A Multicentre, Open-Label, Randomised Phase III Study Comparing a New Levonorgestrel Intrauterine Contraceptive System (LNG-IUS 8) with Combined Oral Contraception in Young Women of Reproductive Age.” European Journal of Contraception & Reproductive Health Care, vol. 21, no. 5, Oct. 2016, pp. 372–79. EBSCOhost, https://doi.org/10.1080/13625187.2016.1212987.

APA

Borgatta, L., Buhling, K. J., Rybowski, S., Roth, K., & Rosen, K. (2016). A multicentre, open-label, randomised phase III study comparing a new levonorgestrel intrauterine contraceptive system (LNG-IUS 8) with combined oral contraception in young women of reproductive age. European Journal of Contraception & Reproductive Health Care, 21(5), 372–379. https://doi.org/10.1080/13625187.2016.1212987

Chicago

Borgatta, Lynn, Kai J. Buhling, Sarah Rybowski, Katrin Roth, and Kimberly Rosen. 2016. “A Multicentre, Open-Label, Randomised Phase III Study Comparing a New Levonorgestrel Intrauterine Contraceptive System (LNG-IUS 8) with Combined Oral Contraception in Young Women of Reproductive Age.” European Journal of Contraception & Reproductive Health Care 21 (5): 372–79. doi:10.1080/13625187.2016.1212987.